Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Leukemia. 2016 Jul;30(7):1606-9. doi: 10.1038/leu.2016.6. Epub 2016 Feb 3.

Z Chen^{1

2}, J E Cortes³, J L Jorgensen¹, W Wang¹, C C Yin¹, M J You¹, E Jabbour², H M Kantarjian², L J Medeiros¹, S Hu¹

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
³ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types